A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Clinical trial NCT01928329 · COMPLETED
Trial details
- NCT number
- NCT01928329
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2018-06-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.